• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物性肝损伤——2023年最新进展

Drug induced liver injury - a 2023 update.

作者信息

Allison Rebecca, Guraka Asha, Shawa Isaac Thom, Tripathi Gyan, Moritz Wolfgang, Kermanizadeh Ali

机构信息

College of Science and Technology, University of Derby, Derby, UK.

School of Science and Technology, Nottingham Trent University, Nottingham, UK.

出版信息

J Toxicol Environ Health B Crit Rev. 2023 Nov 17;26(8):442-467. doi: 10.1080/10937404.2023.2261848. Epub 2023 Oct 19.

DOI:10.1080/10937404.2023.2261848
PMID:37786264
Abstract

Drug-Induced Liver Injury (DILI) constitutes hepatic damage attributed to drug exposure. DILI may be categorized as hepatocellular, cholestatic or mixed and might also involve immune responses. When DILI occurs in dose-dependent manner, it is referred to as intrinsic, while if the injury occurs spontaneously, it is termed as idiosyncratic. This review predominately focused on idiosyncratic liver injury. The established molecular mechanisms for DILI include (1) mitochondria dysfunction, (2) increased reactive oxygen species levels, (3) presence of elevated apoptosis and necrosis, (4) and bile duct injuries associated with immune mediated pathways. However, it should be emphasized that the underlying mechanisms responsible for DILI are still unknown. Prevention strategies are critical as incidences occur frequently, and treatment options are limited once the injury has developed. The aim of this review was to utilize retrospective cohort studies from across the globe to gain insight into epidemiological patterns. This review considers (1) what is currently known regarding the mechanisms underlying DILI, (2) discusses potential risk factors and (3) implications of the coronavirus pandemic on DILI presentation and research. Future perspectives are also considered and discussed and include potential new biomarkers, causality assessment and reporting methods.

摘要

药物性肝损伤(DILI)是指由药物暴露引起的肝损伤。DILI可分为肝细胞型、胆汁淤积型或混合型,也可能涉及免疫反应。当DILI以剂量依赖方式发生时,称为固有型,而如果损伤自发发生,则称为特异质性。本综述主要关注特异质性肝损伤。已确定的DILI分子机制包括:(1)线粒体功能障碍;(2)活性氧水平升高;(3)细胞凋亡和坏死增加;(4)与免疫介导途径相关的胆管损伤。然而,应该强调的是,DILI的潜在机制仍然未知。预防策略至关重要,因为其发病率频繁发生,而且一旦损伤发生,治疗选择有限。本综述的目的是利用来自全球的回顾性队列研究,深入了解流行病学模式。本综述考虑了:(1)目前已知的DILI潜在机制;(2)讨论潜在风险因素;(3)冠状病毒大流行对DILI表现和研究的影响。还考虑并讨论了未来展望,包括潜在的新生物标志物、因果关系评估和报告方法。

相似文献

1
Drug induced liver injury - a 2023 update.药物性肝损伤——2023年最新进展
J Toxicol Environ Health B Crit Rev. 2023 Nov 17;26(8):442-467. doi: 10.1080/10937404.2023.2261848. Epub 2023 Oct 19.
2
Drug-induced liver injury.药物性肝损伤。
Mayo Clin Proc. 2014 Jan;89(1):95-106. doi: 10.1016/j.mayocp.2013.09.016.
3
Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.药物在人类肝脏中的分子特异性毒理学与动物比较:基本考虑因素。
Int J Mol Sci. 2023 Apr 3;24(7):6663. doi: 10.3390/ijms24076663.
4
Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?药物性肝损伤:生物标志物能否辅助RUCAM进行因果关系评估?
Int J Mol Sci. 2017 Apr 11;18(4):803. doi: 10.3390/ijms18040803.
5
Idiosyncratic drug-induced liver injury: an overview.特异质性药物性肝损伤:概述
Expert Opin Drug Saf. 2007 Nov;6(6):673-84. doi: 10.1517/14740338.6.6.673.
6
Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.COVID-19 患者药物性肝损伤:基于 RUCAM 因果关系评估方法,对 2020/2021 年发表的 996 例 DILI 病例的系统评价。
Int J Mol Sci. 2022 Apr 27;23(9):4828. doi: 10.3390/ijms23094828.
7
Idiosyncratic drug-induced liver injury: an update on the 2007 overview.药物性肝损伤的个体化差异:2007 年综述的更新。
Expert Opin Drug Saf. 2014 Jan;13(1):67-81. doi: 10.1517/14740338.2013.828032. Epub 2013 Sep 27.
8
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.特应性药物性肝损伤问题的研究进展:由于使用 Roussel Uclaf 因果关系评估方法,新的临床和机制分析。
Int J Mol Sci. 2023 Jun 29;24(13):10855. doi: 10.3390/ijms241310855.
9
Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.儿童药物性肝损伤特征:来自 DILIN 前瞻性研究的结果。
J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):182-9. doi: 10.1097/MPG.0b013e31821d6cfd.
10
Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.特异质性药物性肝损伤(DILI)的机制:尚未解决的基本问题。
Ann Transl Med. 2021 Apr;9(8):730. doi: 10.21037/atm-2020-ubih-05.

引用本文的文献

1
Toxin-Induced Liver Injury Following Bear Bile Consumption in a Middle-Aged Female in Bhutan: A Case Report.不丹一名中年女性食用熊胆后发生毒素性肝损伤:病例报告
Clin Case Rep. 2025 Jul 29;13(8):e70692. doi: 10.1002/ccr3.70692. eCollection 2025 Aug.
2
Magnesium Isoglycyrrhizinate Alleviates Alectinib-Induced Hepatotoxicity by Inhibiting Mitochondrial Damage-Mediated Pyroptosis.异甘草酸镁通过抑制线粒体损伤介导的细胞焦亡减轻阿来替尼诱导的肝毒性。
Drug Des Devel Ther. 2025 Jul 22;19:6219-6233. doi: 10.2147/DDDT.S523455. eCollection 2025.
3
Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study.
奥硝唑所致肝损伤:一项多中心研究中罕见不良反应的临床特征及其意义
Biomedicines. 2025 Jul 11;13(7):1695. doi: 10.3390/biomedicines13071695.
4
Risk factors related to significant hepatic inflammation in patients with acute drug-induced liver injury.急性药物性肝损伤患者中与显著肝脏炎症相关的危险因素。
ILIVER. 2024 May 6;3(2):100095. doi: 10.1016/j.iliver.2024.100095. eCollection 2024 Jun.
5
Morin: a promising hepatoprotective agent against drug and chemical-induced liver injury.桑色素:一种有望用于对抗药物和化学物质诱导肝损伤的肝保护剂。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 26. doi: 10.1007/s00210-025-04394-3.
6
Real-world data of Azvudine-induced hepatotoxicity among hospitalized COVID-19 patients in China: a retrospective case-control study.中国住院COVID-19患者中阿兹夫定引起肝毒性的真实世界数据:一项回顾性病例对照研究。
Front Pharmacol. 2025 Jun 4;16:1558054. doi: 10.3389/fphar.2025.1558054. eCollection 2025.
7
'Fulminant hepatic failure' anesthesiologic considerations.暴发性肝衰竭的麻醉学考量
Curr Opin Anaesthesiol. 2025 Aug 1;38(4):503-512. doi: 10.1097/ACO.0000000000001530. Epub 2025 May 26.
8
Functional Liver Cell-Based Platforms in Biomedical Research.生物医学研究中基于功能性肝细胞的平台
Pharmacol Res Perspect. 2025 Jun;13(3):e70128. doi: 10.1002/prp2.70128.
9
The Predictive Role of FGF21 in Acute Liver Injury Caused by Bacterial Infectious Diseases in Critical Care: A Retrospective Cohort Study.FGF21在危重症中细菌性传染病所致急性肝损伤中的预测作用:一项回顾性队列研究
J Inflamm Res. 2025 May 26;18:6795-6806. doi: 10.2147/JIR.S521327. eCollection 2025.
10
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort.NAT2乙酰化状态可预测抗结核治疗期间的肝毒性:多民族队列的累积风险分析
Int J Mol Sci. 2025 Apr 19;26(8):3881. doi: 10.3390/ijms26083881.